Japan News
-
Siemens renews partnership with Japanese lab solutions firm
Japan | News | By BioSpectrum Bureau | 0 Comment | 20 Jul, 2012
Singapore: Sysmex Corporation and Siemens Healthcare Diagnostics have announced the signing of a five-year global supply...Read more
-
Sucampo, Takeda file patent suit against Aunchen
Japan | News | By BioSpectrum Bureau | 0 Comment | 11 Feb, 2013
Singapore: Sucampo (an affiliate of Sucampo Pharmaceuticals), R-Tech Ueno, Takeda Pharmaceutical, and certain affiliate...Read more
-
Chugai to invest $160 mn in Singapore
Japan | Influencers | By BioSpectrum Bureau | 0 Comment | 11 Oct, 2012
Japan's Chugai Pharmaceutical, which pursues cutting-edge biopharmaceutical, antibody, and molecular targeted research t...Read more
-
Eisai cancer drug gets orphan drug designation from Japan
Japan | News | By BioSpectrum Bureau | 0 Comment | 27 Aug, 2012
Singapore: Eisai has received orphan drug designation from Japan's Ministry of Labour, Health and Welfare for its multi...Read more
-
Japan files criminal complaint against Novartis
Japan | News | By BioSpectrum Bureau | 0 Comment | 10 Jan, 2014
Singapore: Japan's health ministry has lodged a criminal complaint against the local wing of the leading Swiss drug make...Read more
-
Daiichi Sankyo enrolls patients for edoxaban trial
Japan | News | By BioSpectrum Bureau | 0 Comment | 30 Oct, 2012
Singapore: Japan-headquartered Daiichi Sankyo has completed patient enrollment in the global Hokusai-VTE phase III study...Read more
-
Daiichi Sankyo extends Medidata Clinical Cloud use to China
Japan | News | By BioSpectrum Bureau | 0 Comment | 07 Aug, 2013
Singapore: Daiichi Sankyo is expanding its use of US-based Medidata Solutions' cloud-based platform to support clinical ...Read more
-
Daiichi, Amplimmune join hands for protein R&D
Japan | News | By BioSpectrum Bureau | 0 Comment | 08 Jan, 2013
Singapore: Daiichi Sankyo and Amplimmune have entered into a strategic collaboration to develop a new therapeutic prote...Read more
-
Sankyo halts phase III trial of cancer drug
Japan | News | By BioSpectrum Bureau | 0 Comment | 04 Oct, 2012
Singapore: The independent Data Monitoring Committee (DMC) of the phase III MARQUEE (Met inhibitor ARQ 197 plus Erlotin...Read more
-
Bioscience firms queue up for Japan market
Japan | Analysis | By BioSpectrum Bureau | 3 Comment | 01 Jun, 2012
Japan, which has the lowest infant mortality rate and highest adult life expectancy in the world, is fast turning into a...Read more
-
Mylan and Pfizer enter deal for EpiPen in Japan
Japan | News | By BioSpectrum Bureau | 0 Comment | 08 Aug, 2012
Singapore: Mylan Specialty, a subsidiary of Mylan, and Pfizer entered into a license agreement, under which Pfizer will ...Read more
-
Eisai, UCL form neuro R&D alliance
Japan | News | By BioSpectrum Bureau | 0 Comment | 14 Dec, 2012
Singapore: University College London (UCL) and Japanese pharmaceutical company Eisai, have entered into a new agreement ...Read more
-
First-of-its-kind stroke symposium concludes in Tokyo
Japan | News | By BioSpectrum Bureau | 0 Comment | 14 Sep, 2012
Singapore: Stroke, the destruction of brain tissue from blockage or rupture of blood vessels, is one of the leading caus...Read more
-
Japan's Eisai to start Down's syndrome therapy test
Japan | News | By BioSpectrum Bureau | 0 Comment | 16 Jul, 2013
Singapore: Japanese pharmaceutical company Eisai has said that it will soon begin therapeutic testing of a drug that it ...Read more
-
Eisai disagrees with IQWiG on epileptic drug
Japan | News | By BioSpectrum Bureau | 0 Comment | 18 Dec, 2012
Singapore: Eisai has expressed strong disappointment with Institute for Quality and Efficiency in Health Care (IQWiG), G...Read more
-
Ono ties up with BioFocus for drug research
Japan | News | By BioSpectrum Bureau | 0 Comment | 04 Sep, 2012
Singapore: Japanese firm Ono Pharmaceutical and BioFocus, a service division of Galapagos and based in the UK, have sign...Read more
-
Sosei completes phase I trial for SO-1105 in Japan
Japan | News | By BioSpectrum Bureau | 0 Comment | 03 Jul, 2012
Singapore: Sosei has successfully completed a Japanese phase I trial for SO-1105 for the treatment of oropharyngeal cand...Read more
-
Millennium announces positive results of orteronel study
Japan | News | By BioSpectrum Bureau | 0 Comment | 06 Jun, 2012
Singapore: Updated results from a phase II study of orteronel, a selective oral 17,20 lyase inhibitor, dosed without pre...Read more
